Showing all 4 results

  • Ceritinib 150 mg

    Ceritinib 150 mg

    0 out of 5
    $380

    SPEXIB (Ceritinib) is a targeted therapy that targets and binds to the tyrosine kinase receptors and inhibits ALK, insulin-like growth factor 1 receptor (IGF-1R), insulin receptor (InsR), and ROS1on the surface of the cell. By binding to these receptors ceritinib blocks an important pathway that promotes cell division.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Afatinib 40 mg

    Afatinib 40 mg

    0 out of 5
    $168

    Afatinib 40 mg is a targeted cancer medicine used to treat non-small cell lung cancer (NSCLC) with specific EGFR mutations. It works by blocking the growth and spread of cancer cells.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Afatinib 30 mg

    Afatinib 30 mg

    0 out of 5
    $136

    Afatinib 30 mg is a targeted therapy used in the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations. It works by blocking abnormal protein signals that cause cancer cells to grow and multiply.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page
  • Afatinib 20 mg

    Afatinib 20 mg

    0 out of 5
    $98

    Afatinib 20 mg is a targeted therapy used in the treatment of non-small cell lung cancer (NSCLC). It works as a tyrosine kinase inhibitor (TKI), blocking the activity of abnormal EGFR proteins that drive cancer cell growth.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page

End of content

End of content